Risk factors for mortality in severe COVID-19: Exploring the interplay of immunomodulatory therapy and coinfection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for mortality in severe COVID-19: Exploring the interplay of immunomodulatory therapy and coinfection
Authors
Keywords
-
Journal
ANAESTHESIA AND INTENSIVE CARE
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-09-17
DOI
10.1177/0310057x231183451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial
- (2023) Justin Z Chen et al. LANCET INFECTIOUS DISEASES
- Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
- (2022) Rifky Balgahom et al. PATHOLOGY
- Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids
- (2022) Arthur M. Albuquerque et al. JAMA Network Open
- Beyond the Pandemic: The Value of Antimicrobial Stewardship
- (2022) Souha S. Kanj et al. Frontiers in Public Health
- The first Australian experience with ward‐based continuous positive airway pressure for COVID‐19 respiratory failure: a retrospective cohort study
- (2022) Benjamin Gerhardy et al. INTERNAL MEDICINE JOURNAL
- Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
- (2021) R. A. Armstrong et al. ANAESTHESIA
- Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
- (2021) Adam Booth et al. PLoS One
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
- (2021) Jackson S. Musuuza et al. PLoS One
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- Complications of Critical COVID-19
- (2021) David M. Maslove et al. CHEST
- Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis
- (2021) Jingwen Peng et al. REVIEWS IN MEDICAL VIROLOGY
- Co-infections in people with COVID-19: a systematic review and meta-analysis
- (2020) Louise Lansbury et al. JOURNAL OF INFECTION
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
- (2020) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now